These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37249551)

  • 1. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. Letter.
    Shah N; Ioffe V
    J Urol; 2023 Aug; 210(2):247-248. PubMed ID: 37249551
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer: surgery versus observation for localized prostate cancer.
    van den Bergh RC; Giannarini G
    Nat Rev Urol; 2014 Jun; 11(6):312-3. PubMed ID: 24818851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.
    Griebling TL
    J Urol; 2015 Feb; 193(2):540. PubMed ID: 25617275
    [No Abstract]   [Full Text] [Related]  

  • 4. Young men with prostate cancer: are they different and how should they be managed?
    Hotston MR; Burden H; Thurairaja R; McFarlane J; Persad RA
    BJU Int; 2007 Jan; 99(1):5-7. PubMed ID: 17227487
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical practice. Localized prostate cancer.
    Walsh PC; DeWeese TL; Eisenberger MA
    N Engl J Med; 2007 Dec; 357(26):2696-705. PubMed ID: 18160689
    [No Abstract]   [Full Text] [Related]  

  • 6. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.
    Wilt TJ; Brawer MK
    J Urol; 1994 Nov; 152(5 Pt 2):1910-4. PubMed ID: 7523736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery no better than observation for localized prostate cancer.
    Printz C
    Cancer; 2012 Nov; 118(22):5452-3. PubMed ID: 23129387
    [No Abstract]   [Full Text] [Related]  

  • 8. Observation in the management of localized prostate cancer.
    Hoff B; Pow-Sang JM
    Cancer Control; 2001; 8(2):151-4. PubMed ID: 11326169
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?].
    Zellweger T; Gasser T
    Praxis (Bern 1994); 2005 Aug; 94(34):1307-8. PubMed ID: 16170999
    [No Abstract]   [Full Text] [Related]  

  • 10. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an optimal management for localized prostate cancer?
    Singh J; Trabulsi EJ; Gomella LG
    Clin Interv Aging; 2010 Aug; 5():187-97. PubMed ID: 20711438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy.
    Neulander EZ; Greene GF; Wajsman Z
    BJU Int; 2003 Nov; 92(7):824. PubMed ID: 14616480
    [No Abstract]   [Full Text] [Related]  

  • 13. The Surgical Management of Prostate Cancer.
    Sebesta EM; Anderson CB
    Semin Oncol; 2017 Oct; 44(5):347-357. PubMed ID: 29580436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with positive surgical margins following radical prostatectomy.
    Richie JP
    Urol Clin North Am; 1994 Nov; 21(4):717-23. PubMed ID: 7526517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy versus observation for localized prostate cancer.
    Wilt TJ; Brawer MK; Jones KM; Barry MJ; Aronson WJ; Fox S; Gingrich JR; Wei JT; Gilhooly P; Grob BM; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Sharifi R; Blank W; Pandya P; Andriole GL; Culkin D; Wheeler T;
    N Engl J Med; 2012 Jul; 367(3):203-13. PubMed ID: 22808955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
    Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H
    Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intervention or expectant management for prostate cancer. The Prostate Cancer Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancer.
    Wilt TJ; Brawer MK
    Semin Urol; 1995 May; 13(2):130-6. PubMed ID: 7638470
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter.
    Montorsi F; Mazzone E; Gandaglia G; Stabile A; Salonia A; Briganti A
    J Urol; 2022 Jul; 208(1):223-224. PubMed ID: 35348370
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum prostate-specific antigen elevation in the post-radical prostatectomy patient.
    Malkowicz SB
    Urol Clin North Am; 1996 Nov; 23(4):665-75. PubMed ID: 8948419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.
    D'Amico AV; Whittington R; Kaplan I; Beard C; Jiroutek M; Malkowicz SB; Wein A; Coleman CN
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1053-8. PubMed ID: 9169812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.